{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:07:18Z","timestamp":1780481238945,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1331\/154434504322904604","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T22:46:49Z","timestamp":1079477209000},"page":"S46-S56","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["New Perspectives on the Pharmacotherapy of Ischemic Stroke"],"prefix":"10.1016","volume":"44","author":[{"given":"J.","family":"Chris Bradberry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong S.K.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/154434504322904604_bb0010","series-title":"Pharmacotherapy: a pathophysiologic approach","first-page":"375","article-title":"Stroke","author":"Bradberry","year":"2002"},{"key":"10.1331\/154434504322904604_bb0015","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","article-title":"Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association","volume":"34","author":"Adams","year":"2003","journal-title":"Stroke"},{"key":"10.1331\/154434504322904604_bb0020","series-title":"Heart disease and stroke statistics 2003 update","author":"American Heart Association","year":"2002"},{"key":"10.1331\/154434504322904604_bb0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/01.STR.27.9.1459","article-title":"Lifetime cost of stroke in the United States","volume":"27","author":"Taylor","year":"1996","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0030","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM199511233332106","article-title":"Primary prevention of stroke","volume":"333","author":"Bronner","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904604_bb0035","author":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)"},{"key":"10.1331\/154434504322904604_bb0040","author":"National Stroke Association"},{"key":"10.1331\/154434504322904604_bb0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.96.2.701","article-title":"American Heart Association prevention conference IV: prevention and rehabilitation of stroke","volume":"96","author":"Helgason","year":"1997","journal-title":"Circulation."},{"key":"10.1331\/154434504322904604_bb0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"Progress Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"10.1331\/154434504322904604_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study","year":"1998","journal-title":"Lancet"},{"key":"10.1331\/154434504322904604_bb0060","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1331\/154434504322904604_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.1997.03550040069040","article-title":"Cholesterol lowering with statin drugs, risk of stroke, and total mortality\u2014an overview of randomized trials","volume":"278","author":"Hebert","year":"1997","journal-title":"JAMA."},{"key":"10.1331\/154434504322904604_bb0070","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1331\/154434504322904604_bb0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.CIR.103.3.387","article-title":"Reduction of stroke events with pravastatin: the prospective pravastatin pooling (PPP) project","volume":"103","author":"Byrington","year":"2001","journal-title":"Circulation."},{"key":"10.1331\/154434504322904604_bb0080","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904604_bb0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/tc.8.2.156","article-title":"Passive smoking as well as active smoking increases the risk of acute stroke","volume":"8","author":"Bonita","year":"1998","journal-title":"Tob Control."},{"key":"10.1331\/154434504322904604_bb0090","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women. The women's health initiative: a randomized trial","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"10.1331\/154434504322904604_bb0095","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904604_bb0100","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.STR.32.6.1349","article-title":"Trends in acute ischemic stroke trials through the 20th century","volume":"32","author":"Kidwell","year":"2001","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0105","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1331\/154434504322904604_bb0110","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.283.18.2395","article-title":"Intravenous ancrod for treatment of acute ischemic stroke. The STAT study: a randomized controlled trial","volume":"283","author":"Sherman","year":"2000","journal-title":"JAMA"},{"key":"10.1331\/154434504322904604_bb0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jama.283.9.1151","article-title":"Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience","volume":"283","author":"Katzan","year":"2000","journal-title":"JAMA."},{"key":"10.1331\/154434504322904604_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.STR.31.1.77","article-title":"Treating acute stroke patients with intravenous tPA: the OSF stroke network experience","volume":"31","author":"Wang","year":"2000","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.STR.31.2.370","article-title":"Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience","volume":"31","author":"Tanne","year":"2000","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0130","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","article-title":"Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study","volume":"55","author":"Marler","year":"2000","journal-title":"Neurology."},{"key":"10.1331\/154434504322904604_bb0135","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.CIR.100.9.1016","article-title":"1999 Update: ACC\/AHA guidelines for the management of patients with acute myocardial infarction. Executive summary and recommendations","volume":"100","year":"1999","journal-title":"Circulation"},{"key":"10.1331\/154434504322904604_bb0140","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","article-title":"Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions","volume":"33","author":"Gladstone","year":"2002","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0145","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation."},{"key":"10.1331\/154434504322904604_bb0150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.59.4.514","article-title":"Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery","volume":"59","author":"Li","year":"2002","journal-title":"Neurology."},{"key":"10.1331\/154434504322904604_bb0155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology."},{"issue":"suppl 1","key":"10.1331\/154434504322904604_bb0160","doi-asserted-by":"crossref","first-page":"300S","DOI":"10.1378\/chest.119.1_suppl.300S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"10.1331\/154434504322904604_bb0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.STR.29.2.415","article-title":"The greater Cincinnati\/northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among blacks","volume":"29","author":"Broderick","year":"1998","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke prevention in atrial fibrillation study. Final results","volume":"84","author":"Anonymous","year":"1991","journal-title":"Circulation"},{"key":"10.1331\/154434504322904604_bb0175","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study","volume":"343","author":"Anonymous","year":"1994","journal-title":"Lancet"},{"key":"10.1331\/154434504322904604_bb0180","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the direct oral thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomized controlled trial","volume":"362","author":"Executive Steering Committee on behalf of the SPORTIF III Investigators","year":"2003","journal-title":"Lancet"},{"key":"10.1331\/154434504322904604_bb0185","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904604_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1331\/154434504322904604_bb0195","author":"Food and Drug Administration"},{"key":"10.1331\/154434504322904604_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent central ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol."},{"key":"10.1331\/154434504322904604_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci."},{"key":"10.1331\/154434504322904604_bb0210","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI17864","article-title":"P2Y12 regulates platelet adhesion\/activation, thrombus growth, and thrombus stability in injured arteries","volume":"112","author":"Andr\u00e9","year":"2003","journal-title":"J Clin Invest."},{"key":"10.1331\/154434504322904604_bb0215","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1331\/154434504322904604_bb0220","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9149(02)02567-5","article-title":"Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus","volume":"90","author":"Bhatt","year":"2002","journal-title":"Am J Cardiol."},{"key":"10.1331\/154434504322904604_bb0225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation (CURE) study","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904604_bb0230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"North American symptomatic carotid endarterectomy trial collaborators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904604_bb0235","first-page":"145","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"The Heart Outcomes Prevention Evaluation study investigators","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904604_bb0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.324.7339.699","article-title":"Use of ramipril in preventing stroke: double-blind randomised trial","volume":"324","author":"Bosch","year":"2002","journal-title":"BMJ."},{"issue":"suppl","key":"10.1331\/154434504322904604_bb0245","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1016\/S0002-9149(01)02323-2","article-title":"From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis","volume":"89","author":"Yusuf","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1331\/154434504322904604_bb0250","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0140-6736(01)07186-0","article-title":"Blood-pressure reduction and cardiovascular risk in HOPE study","volume":"358","author":"Sleight","year":"2001","journal-title":"Lancet."},{"key":"10.1331\/154434504322904604_bb0255","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/01.CIR.103.23.2828","article-title":"Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)","volume":"103","author":"Rubins","year":"2001","journal-title":"Circulation."},{"key":"10.1331\/154434504322904604_bb0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00001573-200107000-00001","article-title":"Statin therapy and stroke prevention","volume":"16","author":"Vaughan","year":"2001","journal-title":"Curr Opin Cardiol."},{"key":"10.1331\/154434504322904604_bb0265","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.CIR.99.2.216","article-title":"Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent (CARE) Study","volume":"99","author":"Plehn","year":"1999","journal-title":"Circulation."},{"key":"10.1331\/154434504322904604_bb0270","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904604_bb0275","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.STR.28.5.946","article-title":"Stroke, statins, and cholesterol: a meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors","volume":"28","author":"Blauw","year":"1997","journal-title":"Stroke."},{"key":"10.1331\/154434504322904604_bb0280","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archinte.1997.00440330039004","article-title":"Reductase inhibitor monotherapy and stroke prevention","volume":"157","author":"Crouse","year":"1997","journal-title":"Arch Intern Med."},{"key":"10.1331\/154434504322904604_bb0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protective Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"issue":"suppl","key":"10.1331\/154434504322904604_bb0290","doi-asserted-by":"crossref","first-page":"33J","DOI":"10.1016\/S0002-9149(01)01882-3","article-title":"Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention","volume":"88","author":"Callahan","year":"2001","journal-title":"Am J Cardiol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115318562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115318562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:53:22Z","timestamp":1550163202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115318562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S1544319115318562"],"URL":"https:\/\/doi.org\/10.1331\/154434504322904604","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}